Under hypoxic conditions, the expression of programmed death ligand 1 (PD-L1), a critical immune checkpoint molecule, is notably upregulated, facilitating tumor immune evasion in some cancers, especially head and neck cancer, cervical cancer and lung cancer [12, 13]. The gene discussed is CD274; the disease is cancer.